Indo Us Bio-Tech Limited (BOM:541304)
101.24
-2.72 (-2.62%)
At close: Apr 28, 2026
Indo Us Bio-Tech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,030 | 2,953 | 4,451 | 2,131 | 619 | 198 | Upgrade
|
| Market Cap Growth | -37.12% | -33.66% | 108.89% | 244.33% | 213.27% | -36.61% | Upgrade
|
| Enterprise Value | 2,301 | 3,094 | 4,565 | 2,258 | 729 | 291 | Upgrade
|
| Last Close Price | 101.24 | 147.25 | 221.77 | 106.16 | 33.72 | 13.51 | Upgrade
|
| PE Ratio | 13.69 | 18.15 | 54.01 | 29.43 | 12.22 | 4.03 | Upgrade
|
| PS Ratio | 1.72 | 2.84 | 6.11 | 3.45 | 1.24 | 0.49 | Upgrade
|
| PB Ratio | 2.34 | 3.76 | 7.09 | 3.91 | 1.61 | 0.93 | Upgrade
|
| P/TBV Ratio | 2.34 | 3.76 | 7.09 | 3.91 | 1.61 | 0.93 | Upgrade
|
| P/FCF Ratio | - | 529.88 | - | - | - | - | Upgrade
|
| P/OCF Ratio | - | 208.03 | 200.36 | 405.26 | 22.89 | 125.10 | Upgrade
|
| EV/Sales Ratio | 1.95 | 2.98 | 6.27 | 3.66 | 1.46 | 0.73 | Upgrade
|
| EV/EBITDA Ratio | 12.39 | 16.24 | 41.25 | 24.03 | 10.50 | 5.41 | Upgrade
|
| EV/EBIT Ratio | 13.34 | 17.24 | 44.47 | 26.35 | 11.22 | 5.68 | Upgrade
|
| EV/FCF Ratio | - | 555.17 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.19 | 0.23 | 0.21 | 0.33 | 0.54 | Upgrade
|
| Debt / EBITDA Ratio | 1.49 | 0.78 | 1.29 | 1.23 | 1.85 | 2.15 | Upgrade
|
| Debt / FCF Ratio | - | 26.63 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.31 | 0.19 | 0.21 | 0.21 | 0.33 | 0.54 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.46 | 0.77 | 1.20 | 1.21 | 1.84 | 2.13 | Upgrade
|
| Net Debt / FCF Ratio | - | 26.18 | -34.02 | -8.80 | -10.12 | -6.37 | Upgrade
|
| Asset Turnover | - | 1.14 | 0.95 | 0.99 | 1.01 | 1.02 | Upgrade
|
| Inventory Turnover | - | 1.14 | 1.19 | 1.73 | 1.95 | 2.31 | Upgrade
|
| Quick Ratio | - | 0.93 | 1.07 | 2.04 | 1.68 | 1.37 | Upgrade
|
| Current Ratio | - | 5.31 | 3.88 | 4.87 | 3.81 | 2.11 | Upgrade
|
| Return on Equity (ROE) | - | 23.03% | 14.06% | 15.57% | 16.92% | 25.94% | Upgrade
|
| Return on Assets (ROA) | - | 12.31% | 8.34% | 8.57% | 8.18% | 8.16% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.59% | 20.89% | 13.56% | 14.34% | 14.74% | 17.78% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 22.00% | 15.70% | 15.00% | 15.00% | 20.00% | Upgrade
|
| Earnings Yield | 7.31% | 5.51% | 1.85% | 3.40% | 8.18% | 24.81% | Upgrade
|
| FCF Yield | - | 0.19% | -0.09% | -0.61% | -2.04% | -9.09% | Upgrade
|
| Dividend Yield | 0.25% | 0.17% | - | - | 0.37% | - | Upgrade
|
| Payout Ratio | - | 3.08% | - | - | 3.00% | - | Upgrade
|
| Buyback Yield / Dilution | 0.04% | - | -3.95% | -57.60% | 15.96% | - | Upgrade
|
| Total Shareholder Return | 0.28% | 0.17% | -3.95% | -57.60% | 16.33% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.